Hopp til innhold
NHI.no
Annonse

Unormal hårvekst, veiviser: Når bør du søke lege?

  • Unormal behåring som utvikler seg over kort tid, for eksempel mindre enn ett år
  • Ved økende plager
  • Dersom problemene melder seg etter fylte 20 år
  • Dersom behandling ikke har effekt
Annonse

Dette dokumentet er basert på det profesjonelle dokumentet Hirsutisme . Referanselisten for dette dokumentet vises nedenfor

  1. Bode D, Seehusen DA, Baird D. Hirsutism in women. Am Fam Physician 2012; 85: 373-80. American Family Physician
  2. Rosenfield RL. Hirsutism. N Engl J Med 2005; 353: 2578-88. PubMed
  3. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004; 89: 2745-9. PubMed
  4. Azziz R. The evaluation and management of hirsutism. Obstet Gynecol 2003; 101: 995-1007. PubMed
  5. Atkin SL, Sathyapalan T. Assessment of hirsutism. BMJ Best Practice, last updated Nov 2017. bestpractice.bmj.com
  6. Deplewski D, Rosenfield RL. Role of hormones in pilosebaceous unit development. Endocr Rev 2000; 21: 363-92. PubMed
  7. Hogeveen KN, Cousin P, Pugeat M, Dewailly D, Soudan B, Hammond GL. Human sex hormone-binding globulin variants associated with hyperandrogenism and ovarian dysfunction. J Clin Invest 2002; 109: 973-81. PubMed
  8. Azziz R, Sanchez LA, Knochenhauer ES, et al. Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab 2004; 89: 453-62. PubMed
  9. Kaltsas GA, Isidori AM, Kola BP, et al. The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women. J Clin Endocrinol Metab 2003; 88: 2634-43. PubMed
  10. Souter I, Sanchez LA, Perez M, Bartolucci AA, Azziz R. The prevalence of androgen excess among patients with minimal unwanted hair growth. Am J Obstet Gynecol 2004; 191: 1914-20. PubMed
  11. Martin KA, Chang RJ, Ehrmann DA, et al. Evaluation and treatment of hirsutism in premenopausal women: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2008; 93: 1105-20. PubMed
  12. Elamin MB, Murad MH, Mullan R, et al. Accuracy of diagnostic tests for Cushing's syndrome: a systematic review and metaanalyses. J Clin Endocrinol Metab 2008; 93: 1553-62. PubMed
  13. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004; 81: 19-25. PubMed
  14. Azziz R. Diagnostic criteria for polycystic ovary syndrome: a reappraisal. Fertil Steril 2005; 83: 1343-6. PubMed
  15. Fassnacht M, Kenn W, Allolio B. Adrenal tumors: how to establish malignancy? J Endocrinol Invest. 2004;27:387-399. PubMed
  16. Koulouri O, Conway GS. A systematic review of commonly used medical treatments for hirsutism in women. Clin Endocrinol (Oxf) 2008; 68: 800-5. PubMed
  17. Balfour JA, McClellan K. Topical eflornithine. Am J Clin Dermatol 2001; 2: 197-201. PubMed
  18. Dierickx CC. Hair removal by lasers and intense pulsed light sources. Dermatol Clin 2002; 20: 135-146. PubMed
  19. Battle EF Jr, Hobbs LM. Laser-assisted hair removal for darker skin types. Dermatol Ther 2004; 17: 177-83. PubMed
  20. Brown J, Farquhar C, Lee O, Toomath R, Jepson RG. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne. Cochrane Database of Systematic Reviews 2009, Issue 2. Art. No.: CD000194. DOI: 10.1002/14651858.CD000194.pub2. DOI
  21. Swiglo BA, Cosma M, Flynn DN, et al. Antiandrogens for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials. J Clin Endocrinol Metab 2008; 93: 1153-60. PubMed
Annonse
Annonse